1. Home
  2. CNH vs EXEL Comparison

CNH vs EXEL Comparison

Compare CNH & EXEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CNH Industrial N.V.

CNH

CNH Industrial N.V.

HOLD

Current Price

$10.17

Market Cap

13.2B

Sector

Industrials

ML Signal

HOLD

Logo Exelixis Inc.

EXEL

Exelixis Inc.

HOLD

Current Price

$41.43

Market Cap

11.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CNH
EXEL
Founded
1842
1994
Country
United Kingdom
United States
Employees
34197
N/A
Industry
Construction/Ag Equipment/Trucks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.2B
11.7B
IPO Year
N/A
2000

Fundamental Metrics

Financial Performance
Metric
CNH
EXEL
Price
$10.17
$41.43
Analyst Decision
Buy
Buy
Analyst Count
13
21
Target Price
$13.38
$46.45
AVG Volume (30 Days)
12.5M
2.7M
Earning Date
01-01-0001
05-04-2026
Dividend Yield
2.35%
N/A
EPS Growth
N/A
57.95
EPS
N/A
2.78
Revenue
N/A
$452,477,000.00
Revenue This Year
N/A
$13.66
Revenue Next Year
$8.31
$13.73
P/E Ratio
$31.00
$15.05
Revenue Growth
N/A
N/A
52 Week Low
$9.00
$32.38
52 Week High
$13.87
$48.74

Technical Indicators

Market Signals
Indicator
CNH
EXEL
Relative Strength Index (RSI) 27.43 44.19
Support Level $9.87 $40.01
Resistance Level $11.15 $44.15
Average True Range (ATR) 0.36 1.24
MACD -0.21 -0.05
Stochastic Oscillator 1.59 33.27

Price Performance

Historical Comparison
CNH
EXEL

About CNH CNH Industrial N.V.

CNH Industrial is the world's second largest manufacturer of agricultural machinery (82% of industrial net sales) as well as a major player in construction equipment (18% of industrial net sales). Its Case and New Holland brands have served farmers for generations. Geographically, agriculture sales are 40% North America, 32% Europe, Middle East, and Africa, 18% South America, and 10% Asia-Pacific. CNH's products are available through a robust independent dealer network, which includes over 2,600 dealer and distribution locations and reach into 164 countries. The construction business leverages over 400 dealers. The company's captive finance arm provides retail financing to its customers as well as wholesale financing for dealers to maintain inventory, which supports sales.

About EXEL Exelixis Inc.

Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.

Share on Social Networks: